Cite
HARVARD Citation
Jiang, H. et al. (2021). Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia. Leukemia & lymphoma. 62 (12), pp. 2949-2956. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jiang, H. et al. (2021). Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia. Leukemia & lymphoma. 62 (12), pp. 2949-2956. [Online].